Dr Charles Duffield Consultant anaesthetist
- Patient age group
- Adults
- Consultant registered on
- 01/07/2008
- Primary medical qualifications
- MBBS
- Gender
- Male
- Services
- Hospitals
Background
Dr Duffield is a consultant anaesthetist with a background in both military and civilian medicine. He graduated from King’s College Medical School in 2008 with a Bachelor of Medicine, Bachelor of Surgery (MBBS) and subsequently commissioned into the British Army as a medical officer.
In 2010, he completed officer training at the Royal Military Academy Sandhurst, embarking on a military career that spanned over a decade, resulting in promotion to lieutenant colonel and completing two operational tours overseas.
Dr Duffield trained in anaesthetics through the North West London Deanery. He undertook advanced fellowships in paediatric anaesthesia at the Evelina London Children’s Hospital, liver transplant anaesthesia at King’s College Hospital, and pre-hospital emergency medicine with the Great North Air Ambulance’s Helicopter Emergency Medical Service (HEMS). Dr Duffield previously held a substantive consultant post at King’s College Hospital with a sub-specialisation in liver transplantation.
Dr Duffield joined Imperial College Healthcare NHS Trust as a substantive consultant in 2025. His areas of expertise include trauma, orthopaedics, HPB, vascular, and neurosurgery.
Research & publications
Garg M, Tsang C, Duffield C, Wood S, Price T. Characteristics, treatment patterns and outcomes of patients with multiple myeloma, including those who are triple class exposed: A retrospective cohort study in England using national cancer registry data. EJHaem 2025: accepted for publication
Popat R., Basu S., Henshaw S., Karunanithi K., Ramasamy K., Singh I., Tailor A., Ali N., Duffield C. Cook G. The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health Service. BJHaem, 2025; 206(3); 805-1021
Rosetto, Duffield, Marsden et al. Prehospital tranexamic acid shortens the interval to administration by half in Major Trauma Networks; a service evaluation. Emergency Medical Journal, 2019;0:1-6
Popat R et al, Popat R., Basu S., Henshaw S., Karunanithi K., Ramasamy K., Singh I., Tailor A., Ali N., Duffield C. Cook G. UK consensus supporting effective introduction of novel treatments for multiple myeloma in the NHS. BSH (2024), Liverpool, Poster 0135
Tsang, Perkins, O’Reilly, Tunaru, Duffield, Price, Wood, Carpenter. Real world characteristics and outcomes for TCE myeloma patients on pomalidomide and dexamethasone. BSH (2024) Liverpool, ePoster
Dempsey J, Duffield C, Tsang C. A systematic literature review on the use of RWE in NICE technology appraisals indicated for multiple myeloma. ISPOR EU (2023) Copenhagen, Poster